FDA approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disorder. This is the first FDA approval of a treatment for LEMS.
Original source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm627093.htm
